Pretargeted Trop-2 ImmunoPET for Rapid, Selective Detection of Pancreatic Tumors
[89Zr]Zr-deferoxamine-Trop-2 and pretargeting with [64Cu]Cu-sarcophagine-tetrazine are viable imaging strategies to quickly identify Trop-2-positive tumors for subsequent Trop-2 therapies. See related commentary by Mori et al., p. 2547.
Authors
- David Bauer (ORCID: https://orcid.org/0000-0002-3051-7997)
- Alexander Bolaender
- Edwin C. Pratt (ORCID: https://orcid.org/0000-0002-6054-6983)
- Jason S. Lewis (ORCID: https://orcid.org/0000-0001-7065-4534)
- Grace Chao
- Mark Castanares
- Komal Mandleywala
- Emily C. Collins
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Eli Lilly (United States) (US)
- Cornell University (US)
- University of Missouri (US)
Publication Details
- Journal
- Clinical Cancer Research
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1158/1078-0432.ccr-24-3098
- Citations
- 9
- Primary Topic
- Advanced biosensing and bioanalysis techniques
- Type
- article
- Field-Weighted Citation Impact
- 7.25
Funders
- National Institutes of Health